针对涉及喉后壁的耐火性主要复发性口腔口炎的apremilast:一个病例报告
Tinglan Yang1, Jiankang Yang2, Qing Liu1
1State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Key Laboratory of Stomatology, Department of Oral Medicine, School of Stomatology, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Oral surgery, oral medicine, oral pathology and oral radiology
|September 14, 2025
概括
一名患有严重,持久的喉 (复发性口腔口炎) 的患者在使用阿普雷米拉斯特时发现了缓解. 这种治疗导致完全愈合和正常化的炎症标志物,表明其对耐火病例的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
背景情况:
- 复发性口腔口炎 (RAS) 可以呈现为严重的,持久的.
- 在RAS中,喉的往往对常规治疗不耐药.
- 升高的炎症标志物如IL-6和C-反应蛋白可能参与其中.
研究的目的:
- 报告一种对标准疗法耐药的严重喉RAS病例.
- 评估阿普雷米拉斯特在治疗持续的后喉的疗效.
- 在此背景下,评估阿普雷米拉斯特对炎症标志物的影响.
主要方法:
- 一个37岁的女性的病例报告,在10个月的病史中患有后喉.
- 排除的其他潜在病因.
- 在常规疗法失败后开始使用阿普雷米拉斯的治疗.
- 愈和炎症标记物的监测 (IL-6,C反应蛋白).
主要成果:
- 这位患者出现了耐火的后喉.
- 实验室测试显示IL-6和C反应蛋白的水平升高.
- 阿普雷米拉斯特治疗导致在3个月内完全愈合.
- 炎症标志物正常化,在8个月的随访期间没有出现新的.
结论:
- 阿普雷米拉斯特在患有严重,耐火性喉RAS的患者中显示出显著的治疗益处.
- 这表明premilast作为类似具有挑战性的病例的潜在治疗选择.
- IL-6和CRP的正常化支持apremilast在RAS中的抗炎作用.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
2.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
2.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.6K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.6K
Acute Pharyngitis
6.6K
Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
6.6K
Chronic Pharyngitis
16.7K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
16.7K
Gastroesophageal Reflux Disease II: Clinical Features and Management
1.1K
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K
Peptic Ulcer Disease IV: Management
804
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
804


